Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sight Sciences (SGHT) EBT (2020 - 2026)

Sight Sciences has reported EBT over the past 6 years, most recently at -$4.2 million for Q4 2025.

  • For Q4 2025, EBT rose 64.82% year-over-year to -$4.2 million; the TTM value through Dec 2025 reached -$38.4 million, up 25.07%, while the annual FY2025 figure was -$38.4 million, 25.07% up from the prior year.
  • EBT for Q4 2025 was -$4.2 million at Sight Sciences, up from -$8.2 million in the prior quarter.
  • Over five years, EBT peaked at -$4.2 million in Q4 2025 and troughed at -$23.8 million in Q2 2022.
  • A 5-year average of -$14.7 million and a median of -$14.4 million in 2023 define the central range for EBT.
  • Biggest five-year swings in EBT: tumbled 112.05% in 2021 and later surged 64.82% in 2025.
  • Year by year, EBT stood at -$15.8 million in 2021, then fell by 6.69% to -$16.9 million in 2022, then skyrocketed by 36.79% to -$10.7 million in 2023, then dropped by 10.55% to -$11.8 million in 2024, then skyrocketed by 64.82% to -$4.2 million in 2025.
  • Business Quant data shows EBT for SGHT at -$4.2 million in Q4 2025, -$8.2 million in Q3 2025, and -$11.9 million in Q2 2025.